Consolidated Portfolio Review Corp Pfizer Inc Transaction History
Consolidated Portfolio Review Corp
- $624 Billion
- Q1 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Pfizer Inc stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 147,854 shares of PFE stock, worth $3.61 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
147,854
Previous 120,313
22.89%
Holding current value
$3.61 Million
Previous $3.19 Billion
17.38%
% of portfolio
0.6%
Previous 0.51%
Shares
6 transactions
Others Institutions Holding PFE
# of Institutions
3,354Shares Held
3.57BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$12.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.4 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.09 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$3.79 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA121MShares$2.94 Billion0.25% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $137B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...